NCT00891371View on ClinicalTrials.gov

Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2013

Conditions
Diarrhea
Interventions
DRUG

lanreotide (Autogel formulation)

Autogel 120mg

Trial Locations (11)

2060

ZNA Antwerpen, Antwerp

2610

AZ Sint-Augustinus, Wilrijk

2650

UZ Antwerpen #2, Edegem

3000

UZ Leuven, Leuven

3600

ZOL, Genk

4000

CHC Cliniques Saint Joseph, Liège

6110

CHU A. Vesale, Montigny-le-Tilleul

8310

AZ Sint Lucas Brugge, Bruges

9000

AZ Maria Middelares, Ghent

UZ Gent, Ghent

9300

OLVZ Aalst, Aalst

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY